AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BALTIMORE -- Controlled-release oxycodone relieves several types of neuropathic pain in patients with diabetes, reported Mark P. Jensen, Ph.D., of the University of Washington, Seattle, and his associates.
After 6 weeks of treatment in a randomized, double-blind study, 82 patients with type 1 or 2 diabetes who received controlled-release oxycodone had significantly more improvement on 6 of 10 types of pain measured by the Neuropathic Pain Scale (NPS), compared with 77 similar patients in a placebo group. The study, funded by Purdue Pharma LP, was presented in poster form at the annual meeting of the American Pain Society.
Patients in the oxycodone group had significant declines in the intense, sharp, hot, dull, unpleasant, and ...